Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|March 19, 2020
Pineoblastoma in children less than six years of age: The Head Start I, II, and III experienceMohamed S Abdelbaki, Mohammad H Abu-Arja, Tom B Davidson, et al.
Journal of Medical Ethics|July 9, 2018
Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trialsArthur L Caplan, J Russell Teagarden, Lisa Kearns, et al.
Acta Neuropathologica Communications|July 20, 2020
Orbital Rosai-Dorfman disease initially diagnosed as IgG4-related disease: a case reportNishanth S Iyengar, Danielle Golub, Michelle W McQuinn, et al.
Blood Advances|May 10, 2023
PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantationA Samer Al-Homsi, Frank Cirrone, Stephanie Wo, et al.
Journal of Neuro-Oncology|November 5, 2018
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trialsDiana S Osorio, Neha Patel, Lingyun Ji, et al.
Journal of Neuro-Oncology|January 31, 2014
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomasKathleen Dorris, Matthew Sobo, Arzu Onar-Thomas, et al.
Pediatric Blood & Cancer|September 20, 2008
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology GroupJonathan L Finlay, Girish Dhall, James M Boyett, et al.
Journal of Neuropathology and Experimental Neurology|August 23, 2022
Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord GliomasMekka R Garcia, Yang Feng, Varshini Vasudevaraja, et al.
Neuro-Oncology Practice|March 18, 2024
Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumorsMargaret Shatara, Megan Blue, Joseph Stanek, et al.
Neuro-Oncology Advances|November 16, 2022
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapySharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, et al.
Pageof 4